ImmunologyNature CommunicationsPeer-reviewed
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Lior Goldberg, Eric R. Haas, Jiaqi Wu…·Xiuli Wang
This study identifies immunometabolic factors in CD19 CAR T cells that predict long-term response in B-ALL patients and suggests mTOR inhibition as a strategy to enhance anti-tumor activity.
3 citationstop 2%